AdAlta Limited

ASX (AUD): AdAlta Limited (1AD)

Last Price

0.002

Today's Change

0.00 (0.00%)

Day's Change

0.002 - 0.002

Trading Volume

3,740,554

Overview

Market Cap

2 Million

Shares Outstanding

1 Billion

Avg Volume

1,274,742

Avg Price (50 Days)

0.00

Avg Price (200 Days)

0.01

PE Ratio

-0.20

EPS

-0.01

Earnings Announcement

22-Aug-2025

Previous Close

0.00

Open

0.00

Day's Range

0.002 - 0.002

Year Range

0.002 - 0.029

Trading Volume

201,869

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

-33.33%

3 Month Change

-77.78%

6 Month Change

-86.67%

Ytd Change

-88.89%

1 Year Change

-92.31%

3 Year Change

-95.83%

5 Year Change

-97.69%

10 Year Change

-99.24%

Max Change

-99.24%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to discover i-bodies that bind to granzyme B; and Carina Biotech Pty Ltd. to develop CAR-T cell products against various solid tumor antigens. AdAlta Limited was incorporated in 2006 and is headquartered in Bundoora, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment